EVIDENCE THAT THE RISKS OF MISOPROSTOL OUTWEIGH ITS BENEFITS IN STABLE CYCLOSPORINE-TREATED RENAL-ALLOGRAFT RECIPIENTS

被引：0
|
作者：
WILKIE, ME [1 ]
BEER, JC [1 ]
NEWMAN, D [1 ]
RAFTERY, MJ [1 ]
MARSH, FP [1 ]
机构：
[1] ROYAL LONDON HOSP,LONDON HOSP MED CTR,DEPT CLIN BIOCHEM,LONDON E1 2AD,ENGLAND
来源：
TRANSPLANTATION | 1992年 / 54卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：565 / 567
页数：3
相关论文
共 50 条
  • [21] DE-NOVO CANCER IN CYCLOSPORINE-TREATED AND NON-CYCLOSPORINE-TREATED ADULT PRIMARY RENAL-ALLOGRAFT RECIPIENTS
    GRUBER, SA
    GILLINGHAM, K
    SOTHERN, RB
    STEPHANIAN, E
    MATAS, AJ
    DUNN, DL
    CLINICAL TRANSPLANTATION, 1994, 8 (04) : 388 - 395
  • [22] MORPHOLOGY OF ISCHEMIC ACUTE-RENAL-FAILURE, NORMAL FUNCTION, AND CYCLOSPORINE TOXICITY IN CYCLOSPORINE-TREATED RENAL-ALLOGRAFT RECIPIENTS
    SOLEZ, K
    RACUSEN, LC
    MARCUSSEN, N
    SLATNIK, I
    KEOWN, P
    BURDICK, JF
    OLSEN, S
    KIDNEY INTERNATIONAL, 1993, 43 (05) : 1058 - 1067
  • [23] ANEMIA ASSOCIATED WITH PREGNANCY IN A CYCLOSPORINE-TREATED RENAL-ALLOGRAFT RECIPIENT
    ZEIDAN, BS
    WALTZER, WC
    MONHEIT, AG
    RAPAPORT, FT
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (04) : 2301 - 2303
  • [24] EFFECT OF CALCIUM-CHANNEL BLOCKERS ON GRAFT OUTCOME IN CYCLOSPORINE-TREATED RENAL-ALLOGRAFT RECIPIENTS
    VASQUEZ, EM
    POLLAK, R
    TRANSPLANTATION, 1995, 60 (08) : 885 - 887
  • [25] THE BENEFICIAL EFFECT OF PRETRANSPLANT BLOOD-TRANSFUSIONS IN CYCLOSPORINE-TREATED CADAVER RENAL-ALLOGRAFT RECIPIENTS
    MELZER, JS
    HUSING, RM
    FEDUSKA, NJ
    TOMLANOVICH, SJ
    VINCENTI, F
    AMEND, WJC
    GAROVOY, M
    SALVATIERRA, O
    TRANSPLANTATION, 1987, 43 (01) : 61 - 64
  • [26] LONG-TERM FOLLOW-UP OF 100 CYCLOSPORINE-TREATED RENAL-ALLOGRAFT RECIPIENTS
    GOLDEN, DL
    TRANSPLANTATION PROCEEDINGS, 1983, 15 (04) : 3176 - 3183
  • [27] INCREASE IN NATURAL-KILLER ACTIVITY IN CYCLOSPORINE-TREATED RENAL-ALLOGRAFT RECIPIENTS DURING REJECTION
    LEFKOWITZ, M
    JORKASKY, D
    KORNBLUTH, J
    HUMAN IMMUNOLOGY, 1987, 19 (02) : 139 - 149
  • [28] IMMUNOLOGICAL MONITORING DURING OKT3 INTERVENTION IN CYCLOSPORINE-TREATED RENAL-ALLOGRAFT RECIPIENTS
    SMITH, WJ
    BURDICK, JF
    PENNINGTON, LR
    WILLIAMS, GM
    TRANSPLANTATION PROCEEDINGS, 1986, 18 (04) : 756 - 757
  • [29] EFFECTS OF PROPHYLACTIC INTERFERON-ALPHA2 ADMINISTRATION IN CYCLOSPORINE-TREATED RENAL-ALLOGRAFT RECIPIENTS
    DENDORFER, U
    HAMMER, C
    SCHLEIBNER, S
    HAUSMANN, B
    CASTRO, LA
    HILLEBRAND, G
    NGUYEN, LH
    LAND, W
    TRANSPLANTATION PROCEEDINGS, 1986, 18 (05) : 1390 - 1392
  • [30] NATURAL-KILLER ACTIVITY AGAINST VIRAL TARGETS IN CYCLOSPORINE-TREATED RENAL-ALLOGRAFT RECIPIENTS
    CAUDA, R
    CITTERIO, F
    TAMBURRINI, E
    POZZETTO, U
    TUMBARELLO, M
    CASTAGNETO, M
    ORTONA, L
    TRANSPLANTATION PROCEEDINGS, 1988, 20 (02) : 186 - 189
12345